191 related articles for article (PubMed ID: 37409874)
1. New insights into cancer: MDM2 binds to the citrullinating enzyme PADI4.
Araujo-Abad S; Rizzuti B; Villamarin-Ortiz A; Pantoja-Uceda D; Moreno-Gonzalez CM; Abian O; Velazquez-Campoy A; Neira JL; de Juan Romero C
Protein Sci; 2023 Aug; 32(8):e4723. PubMed ID: 37409874
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and biophysical characterization of PADI4 supports its involvement in cancer.
Neira JL; Araujo-Abad S; Cámara-Artigas A; Rizzuti B; Abian O; Giudici AM; Velazquez-Campoy A; de Juan Romero C
Arch Biochem Biophys; 2022 Mar; 717():109125. PubMed ID: 35081374
[TBL] [Abstract][Full Text] [Related]
3. The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells.
Araujo-Abad S; Fuentes-Baile M; Rizzuti B; Bazán JF; Villamarin-Ortiz A; Saceda M; Fernández E; Vidal M; Abian O; Velazquez-Campoy A; de Juan Romero C; Neira JL
Int J Biol Macromol; 2023 Aug; 246():125632. PubMed ID: 37399862
[TBL] [Abstract][Full Text] [Related]
4. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.
Shloush J; Vlassov JE; Engson I; Duan S; Saridakis V; Dhe-Paganon S; Raught B; Sheng Y; Arrowsmith CH
J Biol Chem; 2011 Feb; 286(6):4796-808. PubMed ID: 21084285
[TBL] [Abstract][Full Text] [Related]
6. Role of citrullination modification catalyzed by peptidylarginine deiminase 4 in gene transcriptional regulation.
Zhai Q; Wang L; Zhao P; Li T
Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):567-572. PubMed ID: 28472221
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of ubiquitination of synoviolin by PADI4.
Aratani S; Fujita H; Yagishita N; Yamano Y; Okubo Y; Nishioka K; Nakajima T
Mol Med Rep; 2017 Dec; 16(6):9203-9209. PubMed ID: 29039504
[TBL] [Abstract][Full Text] [Related]
8. Intrinsically Disordered Chromatin Protein NUPR1 Binds to the Enzyme PADI4.
Araujo-Abad S; Neira JL; Rizzuti B; García-Morales P; de Juan Romero C; Santofimia-Castaño P; Iovanna J
J Mol Biol; 2023 Apr; 435(8):168033. PubMed ID: 36858171
[TBL] [Abstract][Full Text] [Related]
9. MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism.
Sczaniecka M; Gladstone K; Pettersson S; McLaren L; Huart AS; Wallace M
J Biol Chem; 2012 Apr; 287(17):14052-68. PubMed ID: 22337874
[TBL] [Abstract][Full Text] [Related]
10. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
[TBL] [Abstract][Full Text] [Related]
11. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
Nie J; Xie P; Liu L; Xing G; Chang Z; Yin Y; Tian C; He F; Zhang L
J Biol Chem; 2010 Jul; 285(30):22818-30. PubMed ID: 20484049
[TBL] [Abstract][Full Text] [Related]
12. Autoactivation of the MDM2 E3 ligase by intramolecular interaction.
Cheng Q; Song T; Chen L; Chen J
Mol Cell Biol; 2014 Aug; 34(15):2800-10. PubMed ID: 24842904
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal SAM domain of p73 binds to the N terminus of MDM2.
Neira JL; Díaz-García C; Prieto M; Coutinho A
Biochim Biophys Acta Gen Subj; 2019 Apr; 1863(4):760-770. PubMed ID: 30735716
[TBL] [Abstract][Full Text] [Related]
14. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.
Corcoran CA; Montalbano J; Sun H; He Q; Huang Y; Sheikh MS
J Biol Chem; 2009 Aug; 284(33):21955-21970. PubMed ID: 19483087
[TBL] [Abstract][Full Text] [Related]
17. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
18. P53 mRNA controls p53 activity by managing Mdm2 functions.
Candeias MM; Malbert-Colas L; Powell DJ; Daskalogianni C; Maslon MM; Naski N; Bourougaa K; Calvo F; Fåhraeus R
Nat Cell Biol; 2008 Sep; 10(9):1098-105. PubMed ID: 19160491
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.
Wade M; Li YC; Matani AS; Braun SM; Milanesi F; Rodewald LW; Wahl GM
Oncogene; 2012 Nov; 31(45):4789-97. PubMed ID: 22266850
[TBL] [Abstract][Full Text] [Related]
20. Elaboration of Non-naturally Occurring Helical Tripeptides as p53-MDM2/MDMX Interaction Inhibitors.
Su A; Tabata Y; Aoki K; Sada A; Ohki R; Nagatoishi S; Tsumoto K; Wang S; Otani Y; Ohwada T
Chem Pharm Bull (Tokyo); 2021 Jul; 69(7):681-692. PubMed ID: 33952867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
